Organization founded by Dr. Dobri Kiprov focusing on therapeutic plasma exchange for longevity.
Home to the Conboy Lab (Irina and Michael Conboy).
A non-profit corporation researching new uses for Therapeutic Plasma Exchange.
A non-profit organization conducting small-scale clinical trials on longevity interventions.
A preventative health platform providing advanced diagnostics and vetted therapeutics to detect and treat age-related diseases early.
United States · Company
A health optimization center offering cryotherapy, IV therapy, and biomarker testing in a retail setting.
Therapeutic plasma exchange programs are networks of regional clinics that offer plasmapheresis (a procedure that removes, treats, and returns blood plasma) as a therapeutic intervention for aging, replacing aged plasma with albumin-enriched solutions based on research suggesting that young plasma contains factors that can rejuvenate aged tissues. Longevity clinics are rolling out plasmapheresis suites with standardized protocols, remote supervision capabilities, and bundled biomarker panels that track aging markers, making the therapy accessible beyond research centers and available to patients seeking anti-aging interventions. Companies and clinics are developing these services.
This innovation addresses research suggesting that factors in young blood can have rejuvenating effects, where plasma exchange could potentially transfer beneficial factors or remove harmful ones. By standardizing and scaling the procedure, these programs make it accessible to more people. However, the scientific basis and effectiveness remain areas of active research.
The technology is being explored for longevity applications, where plasma exchange could potentially have anti-aging effects. As research progresses, these programs could become more established. However, ensuring safety, demonstrating effectiveness, and managing costs remain challenges. The technology represents an interesting approach to anti-aging interventions, but requires continued research to establish efficacy and safety. Success could provide new options for healthy aging, but the scientific basis needs further validation and the approach must be carefully evaluated for safety and effectiveness.
